Medulloblastoma is the most malignant pediatric brain tumor. It is believed
to originate from the undifferentiated external granule layer cells in the
cerebellum, but the mechanism of tumorigenesis remains unknown(1-6). Here
we studied three types of human medulloblastoma cells that express markers
corresponding to different levels of neuronal differentiation. They express
ed the neuronal repressor element 1 (RE1) silencing transcription factor/ne
uron-restrictive silencer factor (REST/NRSF; refs. 7-10) at very high level
s compared with either neuronal progenitor NTera2 (NT2) cells or fully diff
erentiated human neuron teratocarcinoma (hNT cells). To counter the effect
of REST/NRSF, we used a recombinant transcription factor, REST-VP16, constr
ucted by replacing repressor domains of REST/NRSF with the activation domai
n of viral protein (VP16). Transient expression of REST-VP16 in medulloblas
toma cells was able to compete with the endogenous REST/NRSF for DNA bindin
g and stimulate neuronal promoters. High-efficiency expression of REST-VP16
mediated by adenovirus vectors (Ad.REST-VP16) in medulloblastoma cells was
able to counter REST/NRSF-mediated repression of neuronal promoters, stimu
late expression of endogenous neuronal genes and trigger apoptosis through
the activation of caspase cascades. Furthermore, intratumoral injection of
Ad.REST-VP16 in established medulloblastoma tumors in nude mice inhibited t
heir growth. Therefore, REST/NRSF may serve as a new target for therapeutic
interventions for medulloblastoma through agents such as REST-VP16.